JANG, Wook,MOON, Young Ho,HA, Tae Hee,SUH, Kwee Hyun
申请号：
SG11201802905T
公开号：
SG11201802905TA
申请日:
2016.10.31
申请国别(地区):
SG
年份:
2018
代理人:
摘要：
The present invention relates to a novel method for preparing thienopyrimidine compound having an activity of selectively inhibiting tyrosine kinase, specifically the mutant epidermal growth factor receptor tyrosine kinase and a novel intermediate used therein. According to the method of the present invention, the industrial mass-production of the compound of Formula 1, which is useful as a therapeutic agent for non-small cell lung cancer induced by the mutant epidermal growth factor receptor tyrosine kinase, can be implemented more conveniently and efficiently than the conventional technology.
